Denis M - Search Results

1

How Can Immune Checkpoint Inhibitors Cause Hyperprogression in Solid Tumors?

Denis M, Duruisseaux M, Brevet M, Dumontet C. Denis M, et al. Front Immunol. 2020 Mar 20;11:492. doi: 10.3389/fimmu.2020.00492. eCollection 2020. Front Immunol. 2020. PMID: 32265935 Free PMC article. Review.

2

The Antitumor Activity of Combinations of Cytotoxic Chemotherapy and Immune Checkpoint Inhibitors Is Model-Dependent.

Grasselly C, Denis M, Bourguignon A, Talhi N, Mathe D, Tourette A, Serre L, Jordheim LP, Matera EL, Dumontet C. Grasselly C, et al. Among authors: denis m. Front Immunol. 2018 Oct 9;9:2100. doi: 10.3389/fimmu.2018.02100. eCollection 2018. Front Immunol. 2018. PMID: 30356816 Free PMC article.

3

In Vivo Syngeneic Tumor Models with Acquired Resistance to Anti-PD-1/PD-L1 Therapies.

Denis M, Grasselly C, Choffour PA, Wierinckx A, Mathé D, Chettab K, Tourette A, Talhi N, Bourguignon A, Birzele F, Kress E, Jordheim LP, Klein C, Matera EL, Dumontet C. Denis M, et al. Cancer Immunol Res. 2022 Aug 3;10(8):1013-1027. doi: 10.1158/2326-6066.CIR-21-0802. Cancer Immunol Res. 2022. PMID: 35679518

4

Netrin-1 expression and targeting in multiple myeloma.

Fahed D, Chettab A, Mathe D, Denis M, Traverse-Glehen A, Karlin L, Perrial E, Dumontet C. Fahed D, et al. Among authors: denis m. Leuk Lymphoma. 2022 Feb;63(2):395-403. doi: 10.1080/10428194.2021.1984459. Epub 2021 Sep 29. Leuk Lymphoma. 2022. PMID: 34585999

5

Cell-mediated suppression of HIV-specific cytotoxic T lymphocytes.

Joly P, Guillon JM, Mayaud C, Plata F, Theodorou I, Denis M, Debre P, Autran B. Joly P, et al. Among authors: denis m. J Immunol. 1989 Oct 1;143(7):2193-201. J Immunol. 1989. PMID: 2476500

6

[Lymphocytic alveolitis in the early stages of HIV infection: correlation with biological and prognostic factors].

Quint L, Autran B, Guillon JM, Parrot A, Denis M, Debre P, Mayaud CM, Akoun GM. Quint L, et al. Among authors: denis m. Rev Mal Respir. 1992;9(2):155-62. Rev Mal Respir. 1992. PMID: 1348863 French.

7

Minocycline-induced cell-mediated hypersensitivity pneumonitis.

Guillon JM, Joly P, Autran B, Denis M, Akoun G, Debré P, Mayaud C. Guillon JM, et al. Among authors: denis m. Ann Intern Med. 1992 Sep 15;117(6):476-81. doi: 10.7326/0003-4819-117-6-476. Ann Intern Med. 1992. PMID: 1503350

8

T-cell-mediated cytotoxicity against HIV in seropositive patients: a physiopathological approach.

Autran B, Joly P, Guillon JM, Denis M, Mayaud C, Debré P. Autran B, et al. Among authors: denis m. Res Immunol. 1989 Jan;140(1):103-7; discussion 120-1. doi: 10.1016/0923-2494(89)90013-8. Res Immunol. 1989. PMID: 2657906 Review. No abstract available.

9

Evidence for a cytotoxic T-lymphocyte alveolitis in human immunodeficiency virus-infected patients.

Autran B, Mayaud CM, Raphael M, Plata F, Denis M, Bourguin A, Guillon JM, Debre P, Akoun G. Autran B, et al. Among authors: denis m. AIDS. 1988 Jun;2(3):179-83. AIDS. 1988. PMID: 3134912

10

Increased lung epithelial permeability in HIV-infected patients with isolated cytotoxic T-lymphocytic alveolitis.

Meignan M, Guillon JM, Denis M, Joly P, Rosso J, Carette MF, Baud L, Parquin F, Plata F, Debre P, et al. Meignan M, et al. Among authors: denis m. Am Rev Respir Dis. 1990 May;141(5 Pt 1):1241-8. doi: 10.1164/ajrccm/141.5_Pt_1.1241. Am Rev Respir Dis. 1990. PMID: 2111107

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

866 results

Search Page